ARTICLE | Clinical News
Tasisulam: Phase III started
December 21, 2009 8:00 AM UTC
This quarter, Eli Lilly began an open-label Phase III trial in 800 patients to compare IV tasisulam given monthly vs. paclitaxel given on days 1, 8, and 15 of 28-day cycle. ...